Behcet's disease;De ziekte van Behcet

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 4, 1999, Pages 177-180

  Hoopen Neumann, H Ten ^a   Van Der Meijden, W I ^a   Van Hagen, P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CYCLOSPORIN; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; APHTHOUS STOMATITIS; ARTICLE; BEHCET DISEASE; CASE REPORT; DOMINICAN REPUBLIC; FEMALE; GENITAL ULCER; HUMAN; IMMUNOMODULATION; MOROCCO; SKIN ULCER; SYMPTOMATOLOGY; TURKEY (REPUBLIC); DIFFERENTIAL DIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; UVEITIS; VULVA DISEASE;

ADULT; BEHCET SYNDROME; COLCHICINE; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISONE; SEXUALLY TRANSMITTED DISEASES; STOMATITIS, APHTHOUS; TREATMENT OUTCOME; UVEITIS; VULVAR DISEASES;

EID: 0033596451     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. al-Aboosi MM, al Salem M, Saadeh A, al-Jamal M, Hijawi M, Khammash M, et al. Behçet's disease: clinical study of Jordanian patients. Int J Dermatol 1996;35:623-5.
2. Yazici H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoglu AÜ. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984;43:74-5.
3. Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol 1995;34:159-65.
4. Atmaca LS, Idil A, Batioglu F. A descriptive study on Behçet's disease. Acta Ophthalmol Scand 1996;74:403-6.
5. Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Özyazgan Y, Özdogan H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-9.
6. Dührsen U, Kirch W, Brittinger G, Ohnhaus EE, Reinwein D. Das Behçet-Syndrom. Zusammenstellung von 12 Krankheitsverläufen und Literaturübersicht. Schweiz Med Wochenschr 1984;114:1058-68.
7. Chen KR, Kawahara Y, Miyakawa S, Nishikawa T. Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients. J Am Acad Dermatol 1997;36(5 Pt 1):689-96.
8. O'Duffy JD. Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990;16:423-31.
9. Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H. Tüzüner N, et al. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 1994;33:48-51.
10. Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996;347:789-94.
11. Yurdakul S, Yazici H, Tüzün Y, Pazarli H, Yalcin B, Altac M, et al. The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis 1983;42:505-15.
12. Yazici H, Basaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, et al. The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996;35:139-41.
13. Houston KA, O'Duffy JD, McDuffie FC. Behçet's disease associated with a lymphoproliferative disorder, mixed cryoglobulinemia, and an immune complex mediated vasculitis. J Rheumatol 1978; 5:217-23.
14. Hamuryudan V, Mat C, Saip S, Özyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:443-50.
15. Hamuryudan V, Özyazgan Y, Hizli N, Mat C, Yurdakul S, Tüzün Y, et al. Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997;40:769-74.
16. Hamuryudan V, Moral F, Yurdakul S, Mat C, Tüzün Y, Özyazgan Y, et al. Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol 1994;21:1098-100.
17. Feron EJ, Rothova A, Hagen PM van, Baarsma GS, Suttorp-Schulten MSA. Interferon-alpha 2b for refractory ocular Behçet's disease [letter]. Lancet 1994;343:7428.
18. Avci O, Gürler N, Günes AT. Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease. J Am Acad Dermatol 1997;36(5 Pt 1):796-7.
19. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.